US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

CNTG

Centogene NV (CNTG)

Centogene NV

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CNTG

1 2 3 4 5 6 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
31/05/2024	15:30	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CNTG	Centogene NV
31/05/2024	15:30	GlobeNewswire Inc.	CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting	NASDAQ:CNTG	Centogene NV
17/05/2024	06:20	Edgar (US Regulatory)	Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).	NASDAQ:CNTG	Centogene NV
15/05/2024	16:17	GlobeNewswire Inc.	CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights	NASDAQ:CNTG	Centogene NV
15/05/2024	16:12	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:CNTG	Centogene NV
15/05/2024	16:10	GlobeNewswire Inc.	CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position	NASDAQ:CNTG	Centogene NV
14/05/2024	07:30	GlobeNewswire Inc.	CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease	NASDAQ:CNTG	Centogene NV
10/05/2024	05:30	GlobeNewswire Inc.	CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients	NASDAQ:CNTG	Centogene NV
02/04/2024	15:30	GlobeNewswire Inc.	CENTOGENE Receives Nasdaq Non-Compliance Notice	NASDAQ:CNTG	Centogene NV
19/03/2024	05:30	GlobeNewswire Inc.	CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders	NASDAQ:CNTG	Centogene NV
29/02/2024	16:00	GlobeNewswire Inc.	CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency	NASDAQ:CNTG	Centogene NV
28/02/2024	05:30	GlobeNewswire Inc.	CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing	NASDAQ:CNTG	Centogene NV
28/02/2024	05:30	GlobeNewswire Inc.	CENTOGENE Explores Strategic Alternatives	NASDAQ:CNTG	Centogene NV
25/01/2024	05:30	GlobeNewswire Inc.	CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration	NASDAQ:CNTG	Centogene NV
24/01/2024	05:30	GlobeNewswire Inc.	CENTOGENE Receives French Research Tax Credit Accreditation	NASDAQ:CNTG	Centogene NV
23/01/2024	05:30	GlobeNewswire Inc.	CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics	NASDAQ:CNTG	Centogene NV
18/01/2024	05:30	GlobeNewswire Inc.	CENTOGENE Announces Preliminary Full Year 2023 Revenue	NASDAQ:CNTG	Centogene NV
19/12/2023	05:30	GlobeNewswire Inc.	CENTOGENE Announces Voting Results of Extraordinary General Meeting	NASDAQ:CNTG	Centogene NV
13/12/2023	05:30	GlobeNewswire Inc.	CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone	NASDAQ:CNTG	Centogene NV
28/11/2023	05:30	GlobeNewswire Inc.	CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction	NASDAQ:CNTG	Centogene NV
14/11/2023	07:30	GlobeNewswire Inc.	CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism	NASDAQ:CNTG	Centogene NV
10/10/2023	05:30	GlobeNewswire Inc.	CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering	NASDAQ:CNTG	Centogene NV
11/09/2023	07:30	GlobeNewswire Inc.	CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:CNTG	Centogene NV
07/09/2023	16:00	GlobeNewswire Inc.	CENTOGENE Reports First Half 2023 Financial Results	NASDAQ:CNTG	Centogene NV
01/09/2023	07:00	GlobeNewswire Inc.	CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients	NASDAQ:CNTG	Centogene NV
31/08/2023	15:30	GlobeNewswire Inc.	CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency	NASDAQ:CNTG	Centogene NV
07/08/2023	05:30	GlobeNewswire Inc.	CENTOGENE to Participate in Upcoming Conferences in August	NASDAQ:CNTG	Centogene NV
14/07/2023	05:30	GlobeNewswire Inc.	CENTOGENE Regains Compliance With Nasdaq Listing Requirements	NASDAQ:CNTG	Centogene NV
12/07/2023	06:30	GlobeNewswire Inc.	CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort	NASDAQ:CNTG	Centogene NV
02/07/2023	04:00	PR Newswire (US)	Lifera and CENTOGENE, Enter Strategic Collaboration - Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing	NASDAQ:CNTG	Centogene NV

Showing the most relevant articles for your search:NASDAQ:CNTG

1 2 3 4 5 6 Próxima >

Euro vs US Dollar

Verizon Communications

BNP Paribas (QX)

Deutsche Telekom (QX)

JP Morgan Chase

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones